Ebru Erbay, MD, PhD received her MD degree from Ankara University and PhD in cell and structural biology from the University of Illinois, Urbana-Champaign. She has been working on cellular adaptation to nutrient stress since her doctoral studies, which focused on mTOR signaling. Her postdoctoral studies with Gökhan S. Hotamışlıgil at the Harvard School of Public Health demonstrated the causality of endoplasmic reticulum (ER) stress to hyperlipidemia-induced inflammation and atherosclerosis. Studies published from Dr. Ebay’s lab further demonstrated that highly specific, small molecule modulators of ER's stress responses can reduce atherosclerosis progression. Her lab is a highly collaborative group that works with experts in diverse fields and utilizes the state-of-the-art research technologies to uncover ER's contribution to cellular homeostasis and stress, with a specific focus on immune cells and in cardiovascular syndrome.